Dabigatran, Rivaroxaban, and Warfarin Use

Project Title Dabigatran, Rivaroxaban, and Warfarin Use
Date Posted
Friday, May 3, 2013
Project ID
MSY3_MPR31-p1
Status
Complete
Deliverables
Description

Modular program-based one-time assessment of the use of dabigatran, rivaroxaban, and warfarin in the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Results were generated using Modular Program 1; click here for more information. Programs were executed in June 2012.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
dabigatran
rivaroxaban
warfarin
Population / Cohort
All individuals
Time Period
2010 - 2011
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top